Avodart Drug
Links shared publicly online about this topic
GSK Regulatory Update Avodart (dutasteride)
medicalnewstoday.com — “GlaxoSmithKline (NYSE: GSK) announced that it has re-submitted the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for prostate cancer risk reduction among men at increase” View full resource at medicalnewstoday.com
Most Recently Shared on March 30, 2010 at 2:07 pm By:
GSK Regulatory Update Avodart (dutasteride) http://mnt.to/3zBF #prostate
Avodart might slow prostate cancer
prostate-report.org — “Avodart might slow prostate cancer” View full resource at prostate-report.org
Most Recently Shared on March 1, 2012 at 8:11 pm By:
Avodart might slow prostate cancer: Similar to finasteride (Proscar), the drug dutasteride (Avodart) is sometime... http://t.co/aPkPgE8y
Avodart May Lower Prostate Cancer Risk
webmd.com — “Avodart, a widely prescribed drug used to shrink enlarged prostates, appears to reduce the incidence of prostate cancer in men with an increased risk for the disease.” View full resource at webmd.com
Most Recently Shared on March 31, 2010 at 11:10 pm By:
webMD: Avodart May Lower Prostate Cancer Risk http://bit.ly/aTdCbI Full http://bit.ly/9WeBnl
FDA denies expanded Avodart OK for now -Glaxo
health.yahoo.net — “U.S. health regulators declined to approve GlaxoSmithKline's Avodart enlarged prostate drug for reducing the risk of prostate cancer in men deemed to be at increased risk, the British drugmaker said.” View full resource at health.yahoo.net
Most Recently Shared on January 27, 2011 at 6:27 am By:
FDA denies expanded Avodart OK for now -Glaxo http://ow.ly/1b33BV
FDA denies expanded Avodart OK for now -Glaxo
health.yahoo.net — “U.S. health regulators declined to approve GlaxoSmithKline's Avodart enlarged prostate drug for reducing the risk of prostate cancer in men deemed to be at increased risk, the British drugmaker said.” View full resource at health.yahoo.net
Most Recently Shared on January 27, 2011 at 7:01 am By:
FDA denies expanded Avodart OK for now -Glaxo: U.S. health regulators declined to approve GlaxoSmithKline's Avod... http://bit.ly/eX2Z3M
Avodart, Prostate Drug, Found to Reduce Cancer Risk - NYTimes.com
nytimes.com — “A drug from glaxosmithkline, avodart, reduces the risk of prostate cancer, according to the results of a new large clinical study.” View full resource at nytimes.com
Most Recently Shared on April 28, 2009 at 3:50 am By:
Avodart, Prostate Drug, Found to Reduce Cancer Risk http://bit.ly/8Pk42
The Zoomer Report: Prostate Cancer and Avodart - Topix
topix.com — “The Zoomer Report: Prostate Cancer and Avodart - Topix” View full resource at topix.com
Most Recently Shared on February 25, 2011 at 7:06 pm By:
The Zoomer Report: Prostate Cancer and Avodart: A drug can slow the growth of tumours in men with early, low-ris... http://bit.ly/fYqcsA
Avodart May Lower Prostate Cancer Risk - on RxList
rxlist.com — “A new study shows the risk of prostate cancer appears to be lowered with Avodart, a widely prescribed drug used to shrink enlarged prostates.” View full resource at rxlist.com
Most Recently Shared on April 9, 2010 at 8:22 am By:
Avodart May Lower Prostate Cancer Risk - on RxList http://bit.ly/96hYPx
Avodart Reviewed By FDA Advisory Committee For Prostate Cancer Risk Reduction
medicalnewstoday.com — “GlaxoSmithKline (NYSE: GSK) announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (s” View full resource at medicalnewstoday.com
Most Recently Shared on December 2, 2010 at 3:37 pm By:
Avodart Reviewed By FDA Advisory Committee For Prostate Cancer Risk Reduction GlaxoSmithKline (NYSE: GSK) announced the.. http://dld.bz/8Wrf
FDA denies expanded Avodart OK for now -Glaxo | Reuters
reuters.com — “NEW YORK (Reuters) - U.S. health regulators declined to approve GlaxoSmithKline's Avodart enlarged prostate drug for reducing the risk of prostate cancer in men deemed to be at increased risk, the British” View full resource at reuters.com
Most Recently Shared on January 27, 2011 at 2:12 am By:
FDA denies expanded Avodart OK for now -Glaxo http://reut.rs/faweME
FDA denies expanded Avodart OK for now -Glaxo | Reuters
reuters.com — “NEW YORK (Reuters) - U.S. health regulators declined to approve GlaxoSmithKline's Avodart enlarged prostate drug for reducing the risk of prostate cancer in men deemed to be at increased risk, the British” View full resource at reuters.com
Most Recently Shared on January 27, 2011 at 3:49 am By:
FDA denies expanded Avodart OK for now -Glaxo: NEW YORK (Reuters) - U.S. health regulators declined to app... http://tinyurl.com/4bgtyul
Sexual Side Effects From Propecia, Avodart May Be Irreversible - Drugs.com MedNews
drugs.com — “Drugs frequently prescribed to treat hair loss or an enlarged prostate may contribute to irreversible sexual dysfunction in men, new research finds. Use of duta” View full resource at drugs.com
Most Recently Shared on March 10, 2011 at 8:13 pm By:
Sexual Side Effects From Propecia, Avodart May Be Irreversible: THURSDAY, March 10 -- Drugs frequently pre... http://bit.ly/fzuecv #drug
Avodart as Prostate Cancer Preventer Prompts Skepticism at FDA | NewsInferno
newsinferno.com — “The maker of Avodart wants to market the drug as a way to reduce prostate cancer risks in certain men, but according to a report in The Wall Street Journal, the” View full resource at newsinferno.com
Most Recently Shared on November 30, 2010 at 4:57 pm By:
Avodart as Prostate Cancer Preventer Prompts Skepticism at FDA (NewsInferno): The maker of Avodart wants to mark... http://bit.ly/ebIQpU
Panel Opposes Avodart, Proscar to Prevent Prostate Cancer - WSJ.com
online.wsj.com — “A panel said drugs used to treat enlarged prostates in men shouldn't be used to prevent prostate cancer.” View full resource at online.wsj.com
Most Recently Shared on December 1, 2010 at 11:17 pm By:
Panel Opposes Avodart, Proscar to Prevent Prostate Cancer http://bit.ly/hPKLpt
GSK re-submits sNDA for Avodart to FDA
news-medical.net — “GlaxoSmithKline announced today that it has re-submitted the supplemental New Drug Application for Avodart® (dutasteride) for prostate cancer risk reduction among men at increased risk of developing the disease to the US Food and Drug Administration.” View full resource at news-medical.net
Most Recently Shared on March 30, 2010 at 11:52 am By:
Prostate Cancer: GSK re-submits sNDA for Avodart to FDA: GlaxoSmithKline announced today that it has re-submitted ... http://bit.ly/b8IqY6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Prostate News
-
john clay mchugh
Gainesville, Ga urologist treated for prostate cancer has authored a book on prostate cancer. He has an informative and eclectic prostate cancer blog.
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
Advertisement

